Session Information
Date: Wednesday, June 7, 2017
Session Title: Parkinson's Disease: Psychiatric Manifestations
Session Time: 1:15pm-2:45pm
Location: Exhibit Hall C
Objective: Our purpose is to evaluate and classify visiual hallucination of 52 patients with Parkinson’ s Disease and to detect if there is any relation between hallucinations and demographic and clinical features of patients.
Background: Hallucinations and delusions can be complications of Parkinson’s and do not mean that the person is suffering with a new psychiatric illness. Treatment of hallucinations and delusions (often referred to by health care providers as “psychosis” or “psychotic symptoms”) in PD can be challenging.To ensure proper treatment, the underlying cause must first be identified.
Methods: Patients are questioned about hallucinations during outpatient follow-up. Hallucinations are classified as tactil, auditory and visual. Only patients who see visual hallucinations are included in the study. Visual hallucinations are also subgrouped into human appearance, animals, supernatural figures, scary events and the others. Patients’ gender, job, age, medication, disease duration and Hoehn Yahr stage are taken into consideration in clinical analysis.
Results: 52 patients (25 female, 27 male) who were followed between 2014-2016 are included in the study. Mean age of women is 71.4 and men is 68.8. Mean duration of disease is 10 years in all patients. Disease stage is Hoehn Yahr stage 2 in all patients. 9 patients have more than one type of hallucination figure.28 patients see human figures,13 patients see animal figures, 11 patients see beetle , 5 patients see supernatural events, scared events are experienced by 6 patients, 1 patients sees flower figure. 50 patients take levodopa, 14 patients take rasagilin, 18 patients take dopamine agonist, 7 patients take amantadine. Apomorphine infusion are given to 1 patient and Subthalamic nucleus deep brain stimulation is performed in 5 patients.
Conclusions: Hallucinations are the advanced stage neurophysiatric complications in Parkinson’s Disease. It is not known why patients see different hallucinations but it is thought that these could be related to past life events and also daily event which patients experience.
To cite this abstract in AMA style:
A. Acarer, S. Ciftci, Z. Colakoglu. What do patients with Parkinson’s disease see in their hallucinations? Classification of hallucinations which are seen in Parkinson’s Disease; Single Center Experience [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/what-do-patients-with-parkinsons-disease-see-in-their-hallucinations-classification-of-hallucinations-which-are-seen-in-parkinsons-disease-single-center-experience/. Accessed June 15, 2025.« Back to 2017 International Congress
MDS Abstracts - https://www.mdsabstracts.org/abstract/what-do-patients-with-parkinsons-disease-see-in-their-hallucinations-classification-of-hallucinations-which-are-seen-in-parkinsons-disease-single-center-experience/